IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chilton, P. M.
Right arrow Articles by Mitchell, T. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chilton, P. M.
Right arrow Articles by Mitchell, T. C.
Infection and Immunity, July 2006, p. 4180-4189, Vol. 74, No. 7
0019-9567/06/$08.00+0     doi:10.1128/IAI.01749-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

CD8 T Cells Require Bcl-3 for Maximal Gamma Interferon Production upon Secondary Exposure to Antigen

Paula M. Chilton1 and Thomas C. Mitchell1,2*

The Institute for Cellular Therapeutics,1 the Department of Microbiology and Immunology, University of Louisville, Louisville, Kentucky 402022

Received 28 October 2005/ Returned for modification 5 January 2006/ Accepted 7 April 2006

Adjuvant-induced survival of T cells after antigen activation correlates with increased expression of Bcl-3. Bcl-3 is an NF-{kappa}B/I{kappa}B family member and has been implicated in transcriptional regulation in several cell types. We tested the ability of mice deficient in Bcl-3 (Bcl-3 KO) to exhibit T-cell adjuvant-induced survival after challenge with the superantigen staphylococcal enterotoxin B (SEB), using lipopolysaccharide (LPS) as a natural adjuvant. These studies showed that Bcl-3 is required for secondary gamma interferon (IFN-{gamma}) production by CD8 T cells but not for adjuvant-induced survival effects. Specifically, wild-type and Bcl-3 KO mice exhibited comparable long-term increases in the Vß8+ T-cell populations, indicating no lack of survival in response to adjuvant stimulation in the Bcl-3 KO activated T cells. Ectopic expression of the Bcl-3-related molecules I{kappa}B{alpha}, I{kappa}Bß, and I{kappa}B{varepsilon} in SEB-activated T cells increased survival during in vitro culture in the absence of adjuvant, suggesting that these I{kappa}B molecules could exert a survival function in antigen-activated T cells in place of Bcl-3. However, Vß8+ CD8 T cells from SEB- plus LPS-treated Bcl-3 KO mice produced less IFN-{gamma} upon in vitro restimulation than Vß8+ CD8 T cells from wild-type mice. Therefore, Bcl-3 plays a unique role in the regulation of IFN-{gamma} production in this model system.


* Corresponding author. Mailing address: Institute for Cellular Therapeutics, University of Louisville, 570 South Preston Street, Suite 404, Louisville, KY 40202-1760. Phone: (502) 852-2073. Fax: (502) 852-2085. E-mail: tom.mitchell{at}louisville.edu.

Editor: J. F. Urban, Jr.


Infection and Immunity, July 2006, p. 4180-4189, Vol. 74, No. 7
0019-9567/06/$08.00+0     doi:10.1128/IAI.01749-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2006 by the American Society for Microbiology. All rights reserved.